ABOUT US

From 1986 to 1999, he served as Director of the Diabetes Division and Director of the Eleanor and Joseph Kosow Diabetes Treatment Center, the patient care and clinical research arm of the DRI.

Dr. Goldberg is an active researcher, clinician and teacher with a national reputation. His current major research activity is in the prevention of type 2 diabetes and its complications. He is Principal Investigator of the University of Miami center that is part of the national Diabetes Prevention Program and its continuation study, the DPP Outcomes Study (DPPOS). He has several other research activities in the areas of diabetes and lipid disorders that includes a funded study of the nature and implications of high HDL in type 1 diabetes and continues to publish results from his Community Health and Risk-Reduction for Metabolic Syndrome (CHARMS) study.

Dr. Goldberg provides expert and involved care to patients with type 1 and type 2 diabetes, as well as patients with lipid disorders. His research and clinical background in the areas of insulin resistance, obesity, prevention of type 2 diabetes and its complications, pharmacotherapy of diabetes, and in disadvantaged populations with type 2 diabetes, makes him a leader in the evaluation and management of type 2 diabetes. He is Director of the University of Miami’s Lipid Disorders Clinic and is a certified clinical lipidologist and recognized expert in this area, with a strong research and clinical interest in lipid disorders and their management.

As past Director of the State of Florida and University of Florida Southeastern Florida Regional Diabetes Program from 1986 to 1999, he was responsible for translating current scientific information into clinical application and training for health professionals and patients in the South Florida area.  He is an active and recognized teacher of medical students and postgraduate physicians and participates in the organization of the Division’s Fellowship training program.